The mission of the Uniformed Services University of the Health Sciences is to educate, train and prepare uniformed services health professionals, officers and leaders to directly support the Military Health System, the National Security and National Defense Strategies of the United States and the readiness of our Armed Forces.
Since our first graduating class in 1982, the USU's MDs. Nurses and graduates in biomedical sciences provide exceptional service through service in the U.S. Military and civilian careers of distinction. Today, America's Medical School has 691 enrolled students and 5,043 graduates. Over 1,300 graduates in Biomedical Sciences lead aggressive research in medical research. Today's 663 graduates of the School of Nursing blend science, research and field training in advanced practice and PhD degrees. The USU's Postgraduate Dental College provides advanced degree's to the military's dental community, graduating 72 students since establishment.
The University's research program covers a range of clinical and other topics important to both the military and public health. Infectious diseases, trauma medicine, health maintenance, and cancer are areas of particular strength. Researchers are also making important new efforts in state-of-the-art fields that cut across disciplines, such as genomics, proteomics, and drug-delivery mechanisms.
USU is home to many different Centers and Institutes, which help advance the university's research, education and public service missions. Faculty members and students collaborate with other leading experts at USU's Centers and Institutes on projects that push incredible boundaries across manifold disciplines of biomedical science. Their work is shaping military medicine and world health in many positive, powerful ways.
The USU's military unique curriculum is supported by military professions from all services who teach USU's military and civilian students. All military personnel are supported by the USU Brigade, the Brigade staff are managed by the Military Personnel Office.
AFRRI mission is to preserve the health and performance of U.S. military personnel and to protect humankind through research that advances understanding of the effects of ionizing radiation.
To these ends, the institute collaboratively researches the biological effects of ionizing radiation and provides medical training and emergency response to manage incidents related to radiation exposure.
Dr. Dardzinski is an Associate Professor in the Department of Radiology and Radiological Sciences at USUHS and the PI of the CNRM's Translational Imaging Facility at USUHS. His areas of expertise include development of magnetic resonance imaging (MRI) techniques and optimization of other imaging modalities to improve understanding of disease processes such as traumatic brain injury, stroke, and musculoskeletal disorders. He joined USUHS from the Children’s Hospital of Philadelphia, where he focused on musculoskeletal research and whole-body imaging in children. Dr. Dardzinski received his Ph.D. in Biomedical Engineering from Worcester Polytechnic Institute in 1994 where he employed nuclear magnetic resonance (NMR) to evaluate stroke and tissue oxygenation in animal models via diffusion and fluorine imaging, respectively, under the mentorship of the late Dr. Chris Sotak. He conducted his fellowship at the Pennsylvania State University at Hershey, where he collaborated with Dr. Timothy Mosher to develop “T2 mapping”, a measure of early cartilage disruption that is now widely used in musculoskeletal research and practice. He then joined the faculty at the Cincinnati Children’s Hospital Medical Center for over a decade, where for the last two years he was named Scientific Director of the Imaging Research Center in Radiology, overseeing all imaging research activities within the hospital, with an academic appointment of Professor of Pediatrics, Radiology, and Biomedical Engineering at the University of Cincinnati. Dr. Dardzinski joined Merck in 2007 as Senior Director/Research Fellow, leading a wide variety of imaging efforts across a broad range of therapeutic areas with the goal of developing novel biomarkers for prediction of outcomes in clinical trials, and for discovery of new drug targets.
Dr. Dardzinski has authored over 75 peer-reviewed publications, presented numerous invited talks, and has served on the Scientific Program and Governance Committees of the International Society for Magnetic Resonance in Medicine (ISMRM). He has further served on several NIH grant committees, abstract review committees, doctoral committees, and internal grant and investigational review boards.
Dr. Dardzinski’s research interests focus on the utility of quantitative imaging for biomarker development in disease diagnosis and for the monitoring of therapeutic efficacy in pre-clinical to clinical translational research and drug development.
Uniformed Services University of the Health Sciences 4301 Jones Bridge Road Bethesda, MD 20814